Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Receivables - Net (2019 - 2025)

Historic Receivables - Net for Bicycle Therapeutics (BCYC) over the last 7 years, with Q1 2025 value amounting to $136000.0.

  • Bicycle Therapeutics' Receivables - Net changed N/A to $136000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $136000.0, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2022, which is 10450.0% up from last year.
  • As of Q1 2025, Bicycle Therapeutics' Receivables - Net stood at $136000.0.
  • In the past 5 years, Bicycle Therapeutics' Receivables - Net registered a high of $50.0 million during Q1 2023, and its lowest value of $136000.0 during Q1 2025.
  • For the 5-year period, Bicycle Therapeutics' Receivables - Net averaged around $12.5 million, with its median value being $2.0 million (2022).
  • In the last 5 years, Bicycle Therapeutics' Receivables - Net skyrocketed by 207391.3% in 2023 and then tumbled by 9948.33% in 2024.
  • Bicycle Therapeutics' Receivables - Net (Quarter) stood at $1.0 million in 2021, then surged by 104.5% to $2.0 million in 2022, then soared by 2104.89% to $45.1 million in 2023, then crashed by 99.48% to $233000.0 in 2024, then plummeted by 41.63% to $136000.0 in 2025.
  • Its Receivables - Net was $136000.0 in Q1 2025, compared to $233000.0 in Q2 2024 and $45.1 million in Q2 2023.